Drug intelligence / Profile preview

miR-9

Development stage
Preclinical
Lead developer
McGill University
Modality
Dendritic Cell Vaccines → Immune Effector Cells → Other Cell Types → Cell Therapies, RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Subcutaneous, Intradermal, Intratumoral
01

Overview

miR-9 is a microRNA (miRNA) that plays a critical role in modulating immune responses, particularly within dendritic cells (DCs). It is rapidly upregulated in DCs following stimulation with inflammatory signals such as lipopolysaccharide (LPS). miR-9 functions by targeting and suppressing the expression of various mRNAs that encode negative regulators of gene expression, thereby promoting an activated DC phenotype and enhancing their ability to stimulate T-cell responses. Preclinical research has demonstrated that dendritic cells engineered to overexpress miR-9 can significantly reduce tumor growth in melanoma models, suggesting its potential as a component of cell-based cancer immunotherapies.

Other names
microRNA-9microRNA9microRNA 9miRNA-9miRNA9miRNA 9hsa-miR-9hsa-miR9hsa-miR 9mmu-miR-9mmu-miR9mmu-miR 9
02

Targets

CDH1 (Cadherin-1)NFKB1 (NF-κB1)One-cut homeobox family messenger RNA 3' untranslated regionsPotassium calcium-activated channel subfamily M alpha 1 mRNA with alternative 3′ untranslated regionsREST (Repressor element-1 silencing transcription factor)

Beyond the preview

Go deeper on miR-9.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-9.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call